StonvexLoading…
StonvexStonvexStonvexCore line items from SRZN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.48M | $10.65M | $0.00 | $12.50M |
Operating Income | $-42.09M | $-25.54M | $-45.78M | $-44.34M |
Net Income | $-242.03M | $-63.56M | $-43.04M | $-36.00M |
EPS (Diluted) | $-32.37 | $-21.67 | $-21.33 | $-15.56 |
Total Assets | $98.73M | $48.47M | $46.08M | $89.44M |
Total Liabilities | $286.49M | $69.85M | $8.14M | $13.43M |
Cash & Equivalents | $89.25M | $34.56M | $36.04M | $24.69M |
Free Cash Flow OCF − CapEx | $-30.37M | $-17.65M | $-40.76M | $-44.87M |
Shares Outstanding | 9.78M | 3.26M | 2.06M | 2.01M |